17 February 2022 in Ecotoxicology and Environmental Safety
Carboxin is a heterocyclic systemic fungicide, mainly used to prevent and control grain smut and wheat rust. Although its mammalian toxicity has been reported, its toxicity to acute exposure to aquatic animals is unknown. In our study, we used zebrafish as aquatic organisms to study Carboxin toxicity. Carboxin can cause developmental toxicity and cardiotoxicity in zebrafish embryos. Histopathological staining of cardiac sections reveals structural changes in zebrafish hearts, and fluorescence quantitative PCR results shows the heart developmental genes mRNA expression levels were disrupted significantly. Besides, carboxin can also cause oxidative stress and reactive oxygen species (ROS) accumulation in zebrafish embryos. The accumulation of ROS causes mitochondrial damage, which is where ATP energy is produced. So ATPase activities and gene expression level were measured and significantly decreased after exposure to carboxin. From the confocal images, the number of blood cells in the heart were decreased significantly after carboxin exposure. Besides, Carboxin exposure can inhibit myocardial cell proliferation. These are all causes to the heart failure, eventually leading to embryos death.
1 April 2021 in Environmental Pollution
1 July 2020 in Fitoterapia
29 July 2025 in IEEE Transactions on Instrumentation and Measurement
Three-axis magnetometers (TAMs) are widely employed in a variety of applications,including geological surveys, navigation, and military fields. The interference introduced by the TAM itself and the mounted carrier significantly constrain the effectiveness of these measurements and the ability for magnetic anomaly detection (MAD), especially when the TAM is under shaking movements. Implementing compensation strategies by exploiting the geomagnetic field can reduce the interference. However, the geomagnetic field often encompasses time-varying magnetic noise with the progression of industrialization, which frequently leads to the failure of the TAM compensation. To address this critical challenge, we propose a compensation method that accounts for time-varying magnetic noise. The method first employs an uncompensated TAM to adaptively learn the time-varying magnetic noise, then applies the learned parameters directly within the TAM compensation model. Finally, we significantly reduce the impact of time-varying noise during the TAM compensation. After compensation, the TAM scalar output noise reduced a lot and the ability for MAD improved a lot. The experimental results demonstrate that for a MAD test during shaking movement, the peak-to-peak noise was 135.4 nT without any compensation, which was reduced to 36.9 nT by using the nonlinear least square-based calibration method, 31.2 nT by using the particle swarm optimization-based calibration method, and 5.6 nT by using the calibration method proposed in this study. Notably, the magnetic field of the target was 11.7 nT when the it passed by. In this case, only the compensation method proposed in this paper was able to effectively distinguish the target magnetic anomaly signal.
30 July 2026 in Molecular Cancer Research
Neuroendocrine prostate cancer (NEPC) is an aggressive and therapy-resistant subtype of advanced prostate cancer characterized by poor prognosis and limited treatment options. Enzalutamide (Enz), an androgen receptor pathway inhibitor, is a standard second-line therapy for prostate adenocarcinoma. However, Enz resistance promotes not only neuroendocrine differentiation (NED) but also the induction of stemness-associated programs in prostate adenocarcinoma cells. We identified the de novo DNA methyltransferase DNMT3B as a stemness-related gene upregulated in Enz-resistant prostate adenocarcinoma cells and found that its expression is further significantly elevated in NEPC compared with prostate adenocarcinoma. Our studies reveal that DNMT3B is a critical driver of NEPC development by coordinating the regulation of neuroendocrine and stemness transcriptional networks. Genetic inhibition of DNMT3B suppresses NEPC cell proliferation by impairing cell-cycle progression and triggering apoptosis both in vitro and in vivo. DNMT3B loss altered NED-associated, stemness, and epithelial-associated genes. We further uncover a reciprocal regulatory relationship between DNMT3B and the neuroendocrine transcriptional repressor REST. Using a human prostate cell transformation model that recapitulates NEPC evolution, we demonstrate that DNMT3B is required for both the initiation and maintenance of the NEPC phenotype. Finally, pharmacologic inhibition of DNMT3B with the selective inhibitor nanaomycin A reduces NEPC tumor growth and suppresses NED and stemness marker expression without apparent acute toxicity in vivo. Implications: DNMT3B drives therapy-induced lineage plasticity in prostate cancer, and its inhibition suppresses NEPC growth and differentiation, highlighting it as a promising therapeutic target for treatment-resistant disease.